111 related articles for article (PubMed ID: 16787954)
1. Reversing methicillin resistance in MRSA using a bacterial transforming agent.
Carey BE; Dancer SJ
J Antimicrob Chemother; 2006 Aug; 58(2):455-7. PubMed ID: 16787954
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.
Kaka AS; Rueda AM; Shelburne SA; Hulten K; Hamill RJ; Musher DM
J Antimicrob Chemother; 2006 Sep; 58(3):680-3. PubMed ID: 16840428
[TBL] [Abstract][Full Text] [Related]
3. Different antibacterial actions of isoflavones isolated from Erythrina poeppigiana against methicillin-resistant Staphylococcus aureus.
Sato M; Tanaka H; Tani N; Nagayama M; Yamaguchi R
Lett Appl Microbiol; 2006 Sep; 43(3):243-8. PubMed ID: 16910926
[TBL] [Abstract][Full Text] [Related]
4. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients.
Skiest DJ; Brown K; Cooper TW; Hoffman-Roberts H; Mussa HR; Elliott AC
J Infect; 2007 May; 54(5):427-34. PubMed ID: 17070598
[TBL] [Abstract][Full Text] [Related]
5. [Mupirocin resistance in methicillin-resistant Staphylococcus aureus strains isolated from wound infections].
Dolapçi I; Karahan ZC; Tekeli A; Koyuncu E; Azap A; Adaleti R
Mikrobiyol Bul; 2007 Jul; 41(3):435-40. PubMed ID: 17933255
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo activities of echinomycin against clinical isolates of Staphylococcus aureus.
Park YS; Shin WS; Kim SK
J Antimicrob Chemother; 2008 Jan; 61(1):163-8. PubMed ID: 17967852
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial resistance in clinical isolates of Staphylococcus aureus from hospital and community sources in southern Jamaica.
Brown PD; Ngeno C
Int J Infect Dis; 2007 May; 11(3):220-5. PubMed ID: 16815064
[TBL] [Abstract][Full Text] [Related]
8. Risk factors associated with methicillin-resistant Staphylococcus aureus infection in patients admitted to the ED.
Viallon A; Marjollet O; Berthelot P; Carricajo A; Guyomarc'h S; Robert F; Zeni F; Bertrand JC
Am J Emerg Med; 2007 Oct; 25(8):880-6. PubMed ID: 17920971
[TBL] [Abstract][Full Text] [Related]
9. Synergic interaction between pomegranate extract and antibiotics against Staphylococcus aureus.
Braga LC; Leite AA; Xavier KG; Takahashi JA; Bemquerer MP; Chartone-Souza E; Nascimento AM
Can J Microbiol; 2005 Jul; 51(7):541-7. PubMed ID: 16175202
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of Caesalpinia sappan on growth and invasion of methicillin-resistant Staphylococcus aureus.
Kim KJ; Yu HH; Jeong SI; Cha JD; Kim SM; You YO
J Ethnopharmacol; 2004 Mar; 91(1):81-7. PubMed ID: 15036473
[TBL] [Abstract][Full Text] [Related]
11. [Methicillin-resistant Staphylococcus aureus (MRSA) in the community].
Vonk AG; Vandenbroucke-Grauls CM
Ned Tijdschr Geneeskd; 2007 Feb; 151(7):401-7. PubMed ID: 17343138
[TBL] [Abstract][Full Text] [Related]
12. Antistaphylococcal activity of the novel cephalosporin CB-181963 (CAB-175).
Miller K; Storey C; Stubbings WJ; Hoyle AM; Hobbs JK; Chopra I
J Antimicrob Chemother; 2005 Apr; 55(4):579-82. PubMed ID: 15722396
[TBL] [Abstract][Full Text] [Related]
13. Prolonged exposure of methicillin-resistant Staphylococcus aureus (MRSA) COL strain to increasing concentrations of oxacillin results in a multidrug-resistant phenotype.
Martins A; Couto I; Aagaard L; Martins M; Viveiros M; Kristiansen JE; Amaral L
Int J Antimicrob Agents; 2007 Mar; 29(3):302-5. PubMed ID: 17276037
[TBL] [Abstract][Full Text] [Related]
14. [Reduced susceptibility to triclosan in methicillin-resistant Staphylococcus aureus].
Wiśniewska K; Piechowicz L; Galiński J
Med Dosw Mikrobiol; 2006; 58(1):11-7. PubMed ID: 16871968
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence of Staphylococcus aureus methicillin-resistant (MRSA) among health care workers].
Fenga C; Foti M; Daidone A; Sturniolo G; Maviglia P; Di Nola C; Polito I; Mondello P
G Ital Med Lav Ergon; 2007; 29(3 Suppl):416-7. PubMed ID: 18409753
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
Barcia-Macay M; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609
[TBL] [Abstract][Full Text] [Related]
17. Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin.
French GL
J Antimicrob Chemother; 2006 Dec; 58(6):1107-17. PubMed ID: 17040922
[TBL] [Abstract][Full Text] [Related]
18. Quercus infectoria: a candidate for the control of methicillin-resistant Staphylococcus aureus infections.
Chusri S; Voravuthikunchai SP
Phytother Res; 2008 Apr; 22(4):560-2. PubMed ID: 18338770
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
Wang Z; Cao B; Liu YM; Gu L; Wang C
Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
[TBL] [Abstract][Full Text] [Related]
20. Clinical, microbiological, and molecular characterization of methicillin-resistant Staphylococcus aureus infections of cats.
Morris DO; Mauldin EA; O'Shea K; Shofer FS; Rankin SC
Am J Vet Res; 2006 Aug; 67(8):1421-5. PubMed ID: 16881856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
